|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2001-3-28
|
|
pubmed:abstractText |
Allergy to Ambrosia is a disease of growing importance in Europe. Injective and non-injective immunotherapy have been recognised as safe and effective but no evidence is currently available for sublingual immunotherapy (SLIT) in patients sensitised to Ambrosia. This study was planned to assess the effects and the safety of SLIT in patients clinically sensitised to Ambrosia.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0301-0546
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
311-7
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:11269898-Administration, Sublingual,
pubmed-meshheading:11269898-Adolescent,
pubmed-meshheading:11269898-Adult,
pubmed-meshheading:11269898-Allergens,
pubmed-meshheading:11269898-Antigens, Plant,
pubmed-meshheading:11269898-Desensitization, Immunologic,
pubmed-meshheading:11269898-Female,
pubmed-meshheading:11269898-Humans,
pubmed-meshheading:11269898-Hypersensitivity,
pubmed-meshheading:11269898-Male,
pubmed-meshheading:11269898-Middle Aged,
pubmed-meshheading:11269898-Nasal Provocation Tests,
pubmed-meshheading:11269898-Plant Proteins,
pubmed-meshheading:11269898-Pollen,
pubmed-meshheading:11269898-Skin Tests
|
|
pubmed:articleTitle |
Effects of sublingual immunotherapy in patients sensitised to Ambrosia. An open controlled study.
|
|
pubmed:affiliation |
Ospedale S. Paolo, Ambulatorio di Allergologia, Milan, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Multicenter Study
|
